Drug Description in Trials / DrugBank / KEGG DRUG


Search results


No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1BOTULINUM TOXIN TYPE A
(Dysport (TN))
[1] Botulinum toxin type A (Dysport Therapeutic)[1] Botulinum toxin type A (Dysport (TN)) 💬 [1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[10] 2, 5, 6, 7, 13, 15, 17, 70, 113, 149 💬
2Botulinum toxin type A (Nabota®) injection into the gastrocnemius muscle
(Dysport (TN))
[1] Botulinum toxin type A (Dysport Therapeutic)[1] Botulinum toxin type A (Dysport (TN)) 💬 [1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 70 💬
3Botulinum Toxin Type A 200U
(Dysport (TN))
[1] Botulinum toxin type A (Dysport Therapeutic)[1] Botulinum toxin type A (Dysport (TN)) 💬 [1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 13 💬
4Botulinum Toxin Type A 300U
(Dysport (TN))
[1] Botulinum toxin type A (Dysport Therapeutic)[1] Botulinum toxin type A (Dysport (TN)) 💬 [1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 13 💬
5CLOSTRIDIUM BOTULINUM TOXIN TYPE A
(Dysport (TN))
[2] Botulinum toxin type A (Dysport Therapeutic),
Clostridium botulinum
[1] Botulinum toxin type A (Dysport (TN)) 💬 [1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 13 💬
6Dysport[1] Botulinum toxin type A (Dysport Therapeutic)[1] Botulinum toxin type A (Dysport (TN)) 💬 [1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[2] 13, 36 💬
7DYSPORT*SC IM 2FL 500U[1] Botulinum toxin type A (Dysport Therapeutic)[1] Botulinum toxin type A (Dysport (TN)) 💬 [1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 13 💬
8DYSPORT®[1] Botulinum toxin type A (Dysport Therapeutic)[1] Botulinum toxin type A (Dysport (TN)) 💬 [1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 13 💬
9Dysport® (Botulinumtoxin A (Btx A))[1] Botulinum toxin type A (Dysport Therapeutic)[1] Botulinum toxin type A (Dysport (TN)) 💬 [1] SNAP25 💬 [2] Insulin secretion, Synaptic vesicle cycle 💬[1] 36 💬